相关实验视频

Updated: May 23, 2025

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

溶性ST2的血水平反映了肺外器官功能障碍,并预测了急性呼吸衰竭的结果

Amy S Labar¹, Bryan C Ulrich², Tyler C Lovelace^3,4

¹Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA.

Critical care medicine

|May 22, 2025

概括

血溶性ST2 (sST2) 水平独立预测急性呼吸衰竭 (ARF) 的死亡率. 升高的sST2与器官功能障碍有关,这表明IL-33/ST2轴是ARF的治疗点.

科学领域:

在重症监护医学的生物标志物.
急性呼吸衰竭的免疫学
介素-33 (IL-33) 信号通路的信号通路.

背景情况:

可溶性ST2 (sST2) 是IL-33的诱受体,这是一个关键的警报.
sST2与急性呼吸衰竭 (ARF) 的不良结果有关.
了解ARF中的sST2分布和关联对于临床管理至关重要.

研究的目的:

评估不同ARF患者队列中的sST2分布.
为了比较血和下呼吸道 (LRT) 的sST2度.
检查sST2与器官功能障碍的关联,亚表型和ARF的结果.

主要方法:

使用ARF患者的多中心队列的观察性研究.
包括1432名ARF患者 (863名非COVID患者,569名COVID-19患者).
在血和LRT标本中测量sST2,并对关联进行统计分析.

主要成果:

非COVID ARF患者的血sST2水平高于COVID-19患者,并且与LRT水平相比明显升高.
血sST2升高与肺外器官功能障碍和高炎症ARF亚表型相关.
血sST2独立预测了ARF患者的30天死亡率,而非幸存者的持续较高水平.

结论:

血sST2是ARF结果的独立预测器,与肺外器官功能障碍密切相关.
血和LRT sST2之间的弱相关性表明主要是系统性起源.
IL-33/ST2轴代表了ARF和多器官功能障碍的潜在治疗标.

关键词:

在 COVID-19 疫情中,急性呼吸困扰综合征是什么严重的呼吸衰竭是急性呼吸衰竭.生物标志物生物标志物增长刺激表达的基因2 可溶性ST2可以溶解.亚现象类型亚现象类型

更多相关视频

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...